Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Jun;13(6):1633–1637. doi: 10.1128/iai.13.6.1633-1637.1976

Cytomegalovirus infection and immunity in renal allograft recipients: assessment of the competence of humoral immunity.

M W Rytel, J Balay
PMCID: PMC420812  PMID: 184042

Abstract

Cytomegalovirus (CMV) infections are prevalent in renal allograft recipients. The purpose of this ongoing study is to attempt to elucidate the mechanism(s) responsible for the enhanced susceptibility to CMV infections on the part of transplant patients and for their apparent inability to eradicate the infection once it starts. The present report assesses the competence of humoral immunity to CMV in renal allograft recipients. The total study population was comprised of 41 renal allograft recipients (10 followed prospectively) and 38 age-matched control subjects. The overall CMV infection rate in renal allograft recipients was 90.2%, and in 11 cohort control subjects it was 45.5%. Active infection was present in 61.0% of transplant patients (24.0% of these had CMV disease) and in 18.2% of the cohorts. THESE DIFFERENCES ARE SIGNIFICANT. CMV complement fixation and neutralization antibody prevalence was similar in 10 patients with renal failure undergoing hemodialysis before transplantation and in 23 control subjects. There was similarly no difference in antibody response between allograft recipients in whom the infection was primary (eight subjects) or secondary (17 subjects). We conclude that despite immunosuppressant therapy (with azathioprine and corticosteroids), humoral immunity to CMV is not impaired in transplant patients with either a primary or secondary infection.

Full text

PDF
1635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaberg T. M., Cesarz T. J., Rytel M. W. Correlation of virology and clinical course of cytomegalovirus retinitis. Am J Ophthalmol. 1972 Sep;74(3):407–415. doi: 10.1016/0002-9394(72)90899-9. [DOI] [PubMed] [Google Scholar]
  2. Andersen H. K., Spencer E. S. Cytomegalovirus infection among renal allograft recipients. Acta Med Scand. 1969 Jul-Aug;186(1-2):7–19. doi: 10.1111/j.0954-6820.1969.tb01432.x. [DOI] [PubMed] [Google Scholar]
  3. Coulson A. S., Lucas Z. J., Condy M., Cohn R. Forty-day fever. An epidemic of cytomegalovirus disease in a renal transplant population. West J Med. 1974 Jan;120(1):1–7. [PMC free article] [PubMed] [Google Scholar]
  4. Craighead J. E., Hanshaw J. B., Carpenter C. B. Cytomegalovirus infection after renal allotransplantation. JAMA. 1967 Sep 4;201(10):725–728. [PubMed] [Google Scholar]
  5. Craighead J. E. Immunologic response to cytomegalovirus infection in renal allograft recipients. Am J Epidemiol. 1969 Dec;90(6):506–513. doi: 10.1093/oxfordjournals.aje.a121096. [DOI] [PubMed] [Google Scholar]
  6. Jordan M. C., Rousseau W., Stewart J. A., Noble G. R., Chin T. D. Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med. 1973 Aug;79(2):153–160. doi: 10.7326/0003-4819-79-2-153. [DOI] [PubMed] [Google Scholar]
  7. Lang D. J., Hanshaw J. B. Cytomegalovirus infection and the postperfusion syndrome. Recognition of primary infections in four patients. N Engl J Med. 1969 May 22;280(21):1145–1149. doi: 10.1056/NEJM196905222802103. [DOI] [PubMed] [Google Scholar]
  8. Luby J. P., Shasby D. M. A sex difference in the prevalence of antibodies to cytomegalovirus. JAMA. 1972 Dec 4;222(10):1290–1291. [PubMed] [Google Scholar]
  9. Montgomerie J. Z., Kalmanson G. M., Guze L. B. Renal failure and infection. Medicine (Baltimore) 1968 Jan;47(1):1–32. doi: 10.1097/00005792-196801000-00001. [DOI] [PubMed] [Google Scholar]
  10. Plummer G. Cytomegaloviruses of man and animals. Prog Med Virol. 1973;15:92–125. [PubMed] [Google Scholar]
  11. Prince A. M., Szmuness W., Millian S. J., David D. S. A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med. 1971 May 20;284(20):1125–1131. doi: 10.1056/NEJM197105202842004. [DOI] [PubMed] [Google Scholar]
  12. Rifkind D., Goodman N., Hill R. B., Jr The clinical significance of cytomegalovirus infection in renal transplant recipients. Ann Intern Med. 1967 Jun;66(6):1116–1128. doi: 10.7326/0003-4819-66-6-1116. [DOI] [PubMed] [Google Scholar]
  13. Rytel M. W., Aaberg T. M., Dee T. H., Heim L. H. Therapy of cytomegalovirus retinitis with transfer factor. Cell Immunol. 1975 Sep;19(1):8–21. doi: 10.1016/0008-8749(75)90287-7. [DOI] [PubMed] [Google Scholar]
  14. Rytel M. W., Balay J. Impaired production of interferon in lymphocytes from immunosuppressed patients. J Infect Dis. 1973 Apr;127(4):445–449. doi: 10.1093/infdis/127.4.445. [DOI] [PubMed] [Google Scholar]
  15. Sanders C. V., Jr, Luby J. P., Sanford J. P., Hull A. R. Suppression of interferon response in lymphocytes from patients with uremia. J Lab Clin Med. 1971 May;77(5):768–776. [PubMed] [Google Scholar]
  16. Spencer E. S. Cytomegalovirus antibody in uremic patients prior to renal transplantation. Scand J Infect Dis. 1974;6(1):1–4. doi: 10.3109/inf.1974.6.issue-1.01. [DOI] [PubMed] [Google Scholar]
  17. Weller T. H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II. N Engl J Med. 1971 Jul 29;285(5):267–274. doi: 10.1056/NEJM197107292850507. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES